acute invasive aspergillosis

acute invasive aspergillosis

an aggressive infection, particularly in severely immunocompromised people, involving the invasion of blood vessels and tissue infarction by Aspergillus fumigatus. The disease often mimics the signs and symptoms of acute bacterial pneumonia.
References in periodicals archive ?
Acute invasive aspergillosis occurs when the immune system fails to prevent Aspergillus spores from entering the bloodstream via the lungs.
Disseminated aspergillosis in an autopsy case of young male
Vfend was initially approved in the US for the primary treatment of acute invasive aspergillosis and salvage therapy for rare but serious infections caused by the pathogens Scedosporium apiospermum and Flusarium spp.
Pfizer receives FDA approval for the use of Vfend to treat esophageal candidiasis
Oral, esophageal, and pharyngeal candidiasis and acute invasive aspergillosis have responded well in clinical trials.
Antifungal Arsenal to expand in 2002. (More Immunocompromised Patients)
Medical browser ?
Full browser ?